Financial Daily from THE HINDU group of publications
Wednesday, Jul 14, 2004

News
Features
Stocks
Cross Currency
Shipping
Archives
Google

Group Sites

Corporate - New Projects


German genomics major MWG sets shop in Bangalore

Madhumathi D.S.

Bangalore , July 13

THIS could be the beginning of the bio rush into the country. European genomics major MWG Biotech AG has chosen Bangalore as its Asia base and has already gone into production mode at its facility at Bommasandra here.

The Munich-based MWG has set shop within 90 days with an initial investment of 400,000 euros in the facility, Dr Volker Muschalek, Chief Operating Officer and number two at the 43.7-million euro, integrated genomic research services provider, told Business Line.

Its only other facility outside Germany is in North Carolina, in the US. Dr Muschalek is in Bangalore as part of the 15-member German team at the ongoing Bangalore Bio 2004. The German contingent is also the largest country-wise at this year's event.

MWG Biotech Pvt Ltd, the Bangalore outfit, came into being in June with a modern lab and 14 employees to start with. It has started producing oligonucleotides. These are synthetic gene sections that are necessary in therapeutics and diagnostics research undertaken by discovery-led pharmaceutical and biotech companies.

By September this year, MWG also plans to start biochip or micro-array services and high-throughput sequencing research in Bangalore. "The long-term plan is to produce lab instruments in India, perhaps after three years for the domestic as well as Asian markets," Dr Muschalek said.

MWG also plans to invest 1 million euros each in its Bangalore outfit during 2005 and 2006.

According to Dr Muschalek, the big picture is clear: "We want to be the top sequencing address for biotech and pharma companies. We are also interested in outsourcing from India for Asia in areas such as genomic information, synthesis, diagnostics and bioinformatics." In the first year, the Bangalore plant is geared to producing oligonucleotides worth 2.5 million euros and is targeting pharma, biotech companies and academia among its clients. A nation-wide distribution network will be shortly put in place. In Europe, MWG is the leading oligonucleotides supplier and offers customised product and service applications "from genome to gene function." It is also credited with having some of Europe's largest and best sequencing labs, and counts some 20,000 customers in synthesis and 5000 in sequencing.

More Stories on : New Projects | Bio-tech & Genetics

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page



Stories in this Section
Skoda plans to set up R&D units


Cummins India signs pact with Purdue University
Grasim to cut output on monsoon delay
EmmayHR sets sights on staffing business
Praj Ind firming up plans to expand overseas operations
BHEL bags Rs 6-cr Italian order
GTL board to meet on July 27
As deadline for Sarbanes-Oxley compliance nears — MNC arms rush to Indian accounting firms
Amul setting up Rs 58-cr powder plant in Gujarat
Italian casual wear company to set up shop in India
German genomics major MWG sets shop in Bangalore
Cargill in pact with Parakh Foods to expand edible oil business
`Steel prices unlikely to shoot up immediately'
Himatsingka plans foray into bed linen
SAIL posts all-time high Q1 production
Harish Krishnamachar quits TVS
Corporates opt for floaters to raise funds
Indal's Kerala unit on the verge of closure



The Hindu Group: Home | About Us | Copyright | Archives | Contacts | Subscription
Group Sites: The Hindu | Business Line | Sportstar | Frontline | The Hindu eBooks | The Hindu Images | Home |

Copyright © 2004, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line